首页> 外文期刊>Proceedings of the National Academy of Sciences of the United States of America >Converting IL-15 to a superagonist by binding to soluble IL-15R alpha
【24h】

Converting IL-15 to a superagonist by binding to soluble IL-15R alpha

机译:通过与可溶性IL-15Rα结合将IL-15转化为超激动剂

获取原文
获取原文并翻译 | 示例
       

摘要

IL-15 is normally presented in vivo as a cell-associated cytokine bound to IL-15R alpha. We show here that the biological activity of soluble IL-15 is much improved after interaction with recombinant soluble IL-15R alpha; after injection, soluble IL-15/IL-15R alpha complexes rapidly induce strong and selective expansion of memory-phenotype CD8(+) cells and natural killer cells. These findings imply that binding of IL-15R alpha to IL-15 may create a conformational change that potentiates IL-15 recognition by the beta gamma(c) receptor on T cells. The enhancing effect of IL-15R alpha binding may explain why IL-15 normally functions as a cell-associated cytokine. Significantly, the results with IL-2, a soluble cytokine, are quite different; thus, IL-2 function is markedly inhibited by binding to soluble IL-2R alpha.
机译:IL-15通常作为结合IL-15Rα的细胞相关细胞因子在体内呈现。我们在这里显示,与重组可溶性IL-15Rα相互作用后,可溶性IL-15的生物学活性大大提高了。注射后,可溶性IL-15 / IL-15Rα复合物迅速诱导记忆表型CD8(+)细胞和自然杀伤细胞的强烈和选择性扩增。这些发现暗示IL-15Rα与IL-15的结合可能会产生构象变化,从而增强T细胞上的βγ(c)受体对IL-15的识别。 IL-15Rα结合的增强作用可以解释为什么IL-15正常充当细胞相关细胞因子。值得注意的是,可溶性细胞因子IL-2的结果是完全不同的。因此,通过与可溶性IL-2Rα结合,IL-2功能被显着抑制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号